Get started
Wave Life Sciences Ltd.Wave Life Sciences Ltd.Wave Life Sciences Ltd.

Wave Life Sciences Ltd.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

WVE trade ideas

Wave Life Sciences (WVE) AnalysisCompany Overview: Wave Life Sciences NASDAQ:WVE is a pioneer in RNA-targeted therapies, focusing on rare genetic diseases and conditions with significant unmet medical needs. Key Growth Catalysts: Breakthrough in RNA Editing 🧬 WVE-006: Demonstrates the first-ever in-human evidence of RNA editing, a historic milestone for RNA medicine. This platform unlocks new opportunities to treat genetic diseases with precision, differentiating Wave from peers. Expanding Obesity Market Opportunity 🌟 WVE-007: A promising GalNAc-siRNA therapy targeting INHBE, addressing the multi-billion-dollar obesity market. Clinical trials begin in Q1 2025, offering a potential blockbuster treatment for obesity—a market in high demand. Duchenne Muscular Dystrophy (DMD) 🚀 WVE-N531: Positive interim data highlights its potential to secure accelerated approval, providing new hope for DMD patients. Innovative Pipeline & Chemistry 🔬 Wave’s PRISM platform and advanced stereopure chemistry give it a competitive edge in RNA therapeutics. A robust pipeline targeting various high-value indications reinforces long-term growth prospects. Investment Outlook: Bullish Stance: We are bullish on WVE above $12.50-$13.00, driven by groundbreaking RNA editing advancements, an expanding obesity opportunity, and promising DMD data. Upside Target: Our price target is $24.00-$25.00, reflecting transformative potential across multiple programs and significant upside in addressing major unmet medical needs. 🔹 Wave Life Sciences—Unlocking the Power of RNA Medicine! #WVE #RNAEditing #Biotech #Innovation
NASDAQ:WVELong
by Richtv_official
$WVE Wave Life Sciences Ltd. Long term Target PT 39 and higherNASDAQ:WVE Wave Life Sciences Ltd. Long term Target PT 39 and higher Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid (RNA) to correct disease-causing mutations, modulate protein activity, restore the production of functional proteins, or reduce the expression of disease-promoting RNAs or proteins. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-003, a mutant huntingtin SNP3 molecule for the treatment of Huntington's disease; WVE-N531, an Exon 53 molecule for the treatment of Duchenne muscular dystrophy; WVE-006, the SERPINA1 molecule for the treatment of Alpha-1 antitrypsin deficiency (AATD); and ATXN3, a discovery stage program for the treatment of spinocerebellar ataxia 3, as well as multiple preclinical programs for CNS disorders, including Alzheimer's and Parkinson's diseases. It has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, and Glaxo Group Limited. The company was incorporated in 2012 and is based in Singapore.
NASDAQ:WVELong
by BADQOMOCAWGOWLD
1
Double Bottom Chart PatternCompany info Wave Life Sciences Ltd., is a clinical-stage genetic medicine company that designs, optimises and produces novel stereopure oligonucleotides through PRISM. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins or modulate protein expression. Both the WVE and AGTC in my other trade idea have the same sector. The main ETF for this sector is the Health Care Select Sector SPDR Fund. However, there is an issue. Both these stocks are near all-time lows while the ETF is near an all-time high. So, the stocks are lagging behind. So, if you are going to trade these stocks be wary that they are going against the general market trend and there could also be other reasons as to why these stocks are not following the market. Double Bottom Analysis Type: Eve and Adam Length between Valleys: 5 weeks Volume Trend: Larger on the left valley Breakeven Failure Rate: 12% Throwback Rate: 65% Average Rise: 50% Price Target: 3.66 Percentage Change: 51% The double bottom analysis for this stock is the same as for AGTC. The length between the two valleys is within the ideal range at 5 weeks. Concerning volume , it is larger on the left side but not significantly. There does seem to be a downward trend of volume going from the left valley to the right valley. But this trend begins at the end of the left valley at the price spike that follows. The great thing about this patterns is, the stock is very close to their all-time lows. The left valley low was the all-time low. This means the stock has great upward potential. However, as stated above, the stock is not following the general market trend. Also, the stock has been on a downward trend since its inception. Regardless, the pattern is following all ideals even though the stock isn't. So, the pattern strengths are 3/5.
NASDAQ:WVELong
by BlackbearTrader
WVE Technical Analysis 🧙WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:WVELong
by trading_as_bus
$WVE can rise in the next daysContextual immersion trading strategy idea. Wave Life Sciences is a clinical-stage genetic medicine company, designs, optimizes, and produces novel stereo pure oligonucleotides through PRISM, a discovery and drug developing platform. The share price rose after good earnings. I see some preconditions the share price will continue growing. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price in the next days. So I opened a long position from $11,16; stop-loss — $10,03. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:WVELong
by KozakHlib
2
The wave that might wash away your bankroll (2)this stock is pretty interesting its goes up big and sells of big. Its like one day they have the cure for cancer and the next they are worthless. Anyhow the trend is pointing upwards so thats what i am betting on! Timing = 1 ( the chart looks weak so this stock could drop big with the market) Volume = 0 ( the big picture shows this stock is moving up and volume is going up which is bullish ) Group strength = 1 (biotechnology looks to be doing okay) Entry = 0 ( I think 24$ is a great level and it completes a ABCD pattern but with the stoploss it very narrow ) Fractal = 0 (this stock doesnt have that much history yet)
NASDAQ:WVELong
by adolphus53